Aktis Oncology Inc (AKTS) Price Prediction & ForecastAKTSAktis Oncology Inc

Alphio's AKTS stock price prediction model matches the current Aktis Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $17.15 (+2.35%). The 1-week path is $16.34 (-2.51%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Aktis Oncology (AKTS) is currently not a strong buy due to its low current price of $15.06, which is significantly below analyst price targets of $40 and $35. However, the RSI is extremely low at 8.904, indicating potential oversold conditions, which could suggest a rebound in the future. The main risk is the company's negative earnings, with a net income of -24,144,000 USD reported for Q2 2026, which raises concerns about its financial health.

Aktis Oncology Inc (AKTS) last closed at $16.76, gaining +2.07%. These facts feed the 1-day and 1-week AKTS price prediction above.